Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Advances in Biochemical Psychopharmacology|January 1, 1981
Glutamic acid in nervous tissue and changes of the taurine content: its implication in the treatment of epilepsyN M van Gelder
Advances in Biochemical Psychopharmacology|January 1, 1981
Neuropeptides and the blood-brain barrierW M Pardridge, H J Frank, E M Cornford, et al.
Advances in Biochemical Psychopharmacology|January 1, 1981
The nucleus tractus solitarius and experimental neurogenic hypertension: evidence for a central neural imbalance hypothesis of hypertensive diseaseD J Reis
Advances in Biochemical Psychopharmacology|January 1, 1981
Biologically active peptide-containing fractions in schizophrenia and childhood autismK L Reichelt, K Hole, A Hamberger, et al.
Advances in Biochemical Psychopharmacology|January 1, 1982
Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practiceV Sebjanic, S Grombein
Advances in Biochemical Psychopharmacology|January 1, 1982
The mode of action of sulpiride as an atypical antidepressant agentP Jenner, C D Marsden
Advances in Biochemical Psychopharmacology|January 1, 1981
Action of GABA on hippocampal neuronsK Krnjević
Advances in Biochemical Psychopharmacology|January 1, 1995
Neuroactive steroid modulation of GABAA receptorsR W Olsen, D W Sapp
Advances in Biochemical Psychopharmacology|January 1, 1988
Drugs of abuse and virus susceptibilityH Friedman, T Klein, S Specter, et al.
Advances in Biochemical Psychopharmacology|January 1, 1992
GABA- and glutamate-gated ion channels as molecular sites of alcohol and anesthetic actionF F Weight, L G Aguayo, G White, et al.
Pageof 16